Anesthesia & Analgesia · 2005 · 47 citations · 14 references
MedicinePharmacologyNeuropharmacologyPain MedicinePharmacodynamicsAnalgesiaPain NeurobiologyPain NeurophysiologyPain PhysiologyReceptor PharmacologyAdenosine Receptor ModulationAdenosine-mediated SuppressionNociceptor PhysiologyPain PharmacologyPhase Response
In Brief Adenosine has shown antinociceptive action via spinal adenosine receptors. There are four types of adenosine receptors: A1, A2A, A2B, and A3. We characterized the nature of types of adenosine receptors for the control of nociception at the spinal level. For nociception, formalin solution (5%, 50 μL) was injected into the hindpaw of male Sprague-Dawley rats. The effects of intrathecal adenosine A1 (CPA), A2A (DPMA), and A3 (IB-MECA) receptor agonists were examined. CPA and IB-MECA produced limited or no effect on the early phase response of the formalin test, respectively, but the two drugs depressed the late phase response. DPMA suppressed both phase responses. CPA was the most potent drug among the three in the late phase. These results suggest that spinal adenosine A1 and A2A receptors may be involved in the modulation of the early and the late phase responses of the formalin test, whereas adenosine A3 receptor may be involved in the regulation of the late phase response. IMPLICATIONS: Intrathecal adenosine A1 and A2A receptor agonists reduced acute pain and inflammatory hyperalgesia in the formalin test. Further, the adenosine A1 receptor agonist was more powerful than adenosine A2A and A3 receptor agonists for attenuating acute pain. In contrast, intrathecal adenosine A3 receptor agonist decreased inflammatory hyperalgesia without affecting acute pain.
14
Receptors for Purines and Pyrimidines
Geoffrey Burnstock, Alexei Verkhratsky · 2012 · 4K citations
Medicine, Biochemistry, Pharmacology +10
Chronic catheterization of the spinal subarachnoid space
Tony L. Yaksh, Thomas A. Rudy · Physiology & Behavior · 1976 · 2.2K citations